![Boston_H_color[33632]_edited.png](https://static.wixstatic.com/media/e60c5c_0b72738a80554196840094a8e387c5ed~mv2.png/v1/fill/w_338,h_77,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Boston_H_color%5B33632%5D_edited.png)
Date: Saturday, September 26, 2020 Time: 9:00 AM - 10:30 AM Central Time
Virtual Symposium Overview This live-streamed virtual symposium will take place on Saturday, September 26 and will be presented on an interactive web platform by 3 renowned experts actively engaged in the care of patients with ovarian cancer using PARP inhibitors. A patient presenter currently receiving PARP therapy will also be featured to share her story.
Target Audience The target audience for this activity is oncology nurses, nurse practitioners, and other clinicians who treat patients with ovarian cancer with PARP inhibitors.
Learning Objectives After participating in this activity, participants should be better able to:
Discuss patient and disease related factors that help identify patients appropriate for PARP inhibitor maintenance therapy
Review clinical trial data of approved and emerging PARP inhibitor therapy strategies
Evaluate nursing interventions and management strategies that help prevent PARP-related adverse events and encourage patient adherence to oral therapies
Examine patient perspectives of PARP inhibitor therapy and nursing approaches that enhanced their experience during treatment
Continuing Education The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation (ANCC). This activity is provided for 1.5 contact hours under ANCC criteria.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation (ANCC) through the joint providership of the University of Nebraska Medical Center College of Nursing Continuing Nursing Education (UNMC CON CNE) (provider) and Bio Ascend.
Agenda 9:00 AM Welcome, Introductions, and Pre-session Polling 9:05 AM Patient Selection for PARP Inhibitor Therapy: What Patient and Disease Factors Impact Treatment Selection? 9:20 AM Frontline and Secondline PARP Maintenance Strategies: Interpreting the Clinical Trial Data 9:40 AM Non-Maintenance Strategies: How to Use PARP Inhibitors in Recurrent Disease 9:55 AM Nursing Strategies for Patients Receiving PARP Inhibitors: Improving Safety and Encouraging Oral Adherence 10:10 AM A Patient's Perspective of PARP Inhibitor Therapy and Relationship With Care Team 10:20 AM Audience Q&A 10:25 AM Recap of Key Points and Post-session Polling 10:30 AM Adjourn
Faculty Paula J. Anastasia, RN, MN, AOCN - Chair Gynecologic-Oncology Clinical Nurse Specialist Department of Obstetrics and Gynecology University of California Los Angeles Los Angeles, California
Shannon Westin, MD, MPH, FACOG Associate Professor Director, Early Drug Development Department of Gynecologic Oncology and Reproductive Medicine The University of Texas MD Anderson Cancer Center Houston, Texas Chrisann Winslow, RN, BSN, MSN(R), AOCN Clinical Nurse Specialist and Research Coordinator Division of Gynecologic Oncology Department of Obstetrics and Gynecology Washington University School of Medicine St. Louis, Missouri
Faculty Disclosure Statement All presenters, planners, and others in a position to control nursing continuing professional development content participating in a University of Nebraska Medical Center College of Nursing Continuing Nursing Education activity are required to disclose relationships with commercial interests. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Disclosure of these commitments and/or relationships is included in activity materials so that participants in the activity may formulate their own judgments in interpreting its content and evaluating its recommendations. Space for this symposium is limited and pre-registration is recommended to ensure your access to this activity. If your plans change and you are no longer able to attend, please cancel your registration to allow others to register. You may cancel at anytime by emailng info@bioascend.com. There is no fee to register for this activity.
Comments